🧬 Imagine a world where your doctor sends a sample... and AI customizes your treatment

In this panel Q&A, speakers explain how an AI‑enabled, personalized phage therapy for pulmonary infections would work from a patient’s perspective. A physician first determines eligibility and sends a sputum sample to the company (Tolka AI). The lab isolates the pathogenic bacteria from the sample, then screens and isolates bacteriophages that specifically target that pathogen. The process involves roughly 15‑20 laboratory and computational steps, which in academic settings currently take about six months and are costly. Tolka AI’s partner handles the bioinformatics, automation, and software engineering needed to accelerate and scale the workflow. The discussion also touches on practical concerns such as blood tests, sample logistics, and the patient’s experience, while acknowledging the challenges of time, cost, and implementation.










